+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?



Enhanced computed tomography or magnetic resonance imaging: a choice between contrast medium-induced nephropathy and nephrogenic systemic fibrosis?



Acta Radiologica 48(6): 593-596




(PDF emailed within 0-6 h: $19.90)

Accession: 052982867

Download citation: RISBibTeXText

PMID: 17611863

DOI: 10.1080/02841850701370717


Related references

Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?. Acta Radiologica 50(9): 965-967, 2009

Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. Journal of the American Society of Nephrology 17(9): 2359-2362, 2006

Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study. Investigative Radiology 49(2): 109-115, 2014

Effects of magnetic resonance imaging contrast agents on human umbilical vein endothelial cells and evaluation of magnetic resonance imaging contrast media-triggered transforming growth factor-beta induction in dermal fibroblasts (HSF) as a model for nephrogenic systemic fibrosis. Investigative Radiology 46(1): 71-76, 2011

Gadolinium-enhanced magnetic resonance imaging, renal failure and nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy. Current Medicinal Chemistry 15(12): 1229-1235, 2008

Nephrogenic systemic fibrosis-like effects of magnetic resonance imaging contrast agents in rats with adenine-induced renal failure. Toxicological Sciences 131(1): 259-270, 2013

Usefulness of combining sequentially acquired gadobenate dimeglumine-enhanced magnetic resonance imaging and resovist-enhanced magnetic resonance imaging for the detection of hepatocellular carcinoma: comparison with computed tomography hepatic arteriography and computed tomography arterioportography using 16-slice multidetector computed tomography. Journal of Computer Assisted Tomography 31(5): 702-711, 2007

Nephrogenic systemic fibrosis versus contrast-induced nephropathy: risks and benefits of contrast-enhanced MR and CT in renally impaired patients. Journal of Magnetic Resonance Imaging 30(6): 1350-1356, 2010

Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. Journal of Urology 180(3): 830-5; Discussion 835, 2008

Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. American Journal of Kidney Diseases 51(6): 966-975, 2008

Diagnosis of colorectal hepatic metastases: Contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging. Journal of Magnetic Resonance Imaging 32(5): 1132-1140, 2011

Nephrogenic systemic fibrosis as an adverse drug reaction of gadolinium-based contrast media for magnetic resonance imaging. Der Radiologe 47(9): 794-799, 2007

Comparisons of computed tomography, contrast-enhanced computed tomography and standing low-field magnetic resonance imaging in horses with lameness localised to the foot. Part 2: Lesion identification. Equine Veterinary Journal 44(2): 149-156, 2012

Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography. European Journal of Radiology 63(1): 120-123, 2007

Comparisons of computed tomography, contrast enhanced computed tomography and standing low-field magnetic resonance imaging in horses with lameness localised to the foot. Part 1: anatomic visualisation scores. Equine Veterinary Journal 44(1): 51-56, 2012